Company news

Puretech Health Plc (LSE:PRTC) news

Puretech Health Plc news releases on 6ix. Latest, Feb 1, 2023: PureTech to Present at SVB Global Biopharma Conf.

View Puretech Health Plc →

Press releases — page 4

PureTech to Present at SVB Global Biopharma Conf.

February 1, 2023

AKLI Positive ADHD Pivotal Data in Kids 13-17 yrs

January 6, 2023

PRTC Provides Recap Ahead of Catalyst-Rich 2023

December 22, 2022

LYT-300 Shows Proof of Principle in Clinical Trial

December 19, 2022

PureTech to Present at J.P. Morgan HC Conference

December 13, 2022

PRTC Leukemia Data at ASH & Begins AML Trial

December 12, 2022

Sonde Gets $19M+ for Voice-Based Health Monitoring

December 9, 2022

Vor Announces AML Clinical Data + Raises $115M

December 7, 2022

PRTC's New Candidate: Oral CBD for Epilepsy/CNS

November 30, 2022

PRTC Presents at Two Upcoming Investor Conferences

November 17, 2022

Gelesis Presents New Data at ObesityWeek 2022

November 2, 2022

PRTC to Present at Credit Suisse Healthcare Conf

November 1, 2022

Offer Talks Terminated

October 11, 2022

PureTech Health plc

October 10, 2022

PRTC to Present at Morgan Stanley Healthcare Conf

September 8, 2022

PRTC LYT-100 Data & IPF Trial Design at ERS Conf

September 5, 2022

GLS Data: Candidate Improved Insulin Sensitivity

August 25, 2022

PRTC's Sonde Partners with Koye Pharmaceuticals

August 24, 2022

PRTC's Akili to Debut on Nasdaq

August 22, 2022

PRTC Receives $115M from Founded Entity Shares

August 9, 2022

Karuna Successful Ph3 KarXT Study in Schizophrenia

August 8, 2022

Akili/Shionogi Begin Ph3 ADHD Study in Japan

August 1, 2022

New Akili Data in Lupus: Better Function in Adults

July 14, 2022

PRTC's Akili Announces Public Company BOD Nominees

July 11, 2022

PRTC Starts LYT-100 IPF Study & Advances LYT-200

June 30, 2022

PRTC's Vedanta Unveils New Manufacturing Facility

June 28, 2022

GLS: New $15M Plenity Pre-Paid Order; $55M Total

June 21, 2022

LYT-300 Achieves Proof-of-Principle in Human Study

June 14, 2022

Akili Adds Another Life Sciences Vet to C-Suite

June 6, 2022

Akili & Roblox (NYSE:RBLX) Partner on EndeavorRx

May 26, 2022

PRTC's Vedanta Presents Data at DDW Annual Meeting

May 24, 2022

PRTC to Present at UBS Healthcare Conference

May 17, 2022

PRTC Presents LYT-100 Data at ATS Conference

May 16, 2022

PRTC Share Buyback Programme Commences Purchases

May 9, 2022

PRTC Announces Share Buyback Programme Up to $50M

May 5, 2022

Gelesis Presents GS200 Weight Loss Data at ECO

May 4, 2022

Gelesis Data: Therapeutic Shows Gut Health Benefit

April 29, 2022

PRTC's Vedanta Publishes VE303 Data

April 13, 2022

Akili Depression Data Published in AJP

April 12, 2022

PRTC Appoints Merck Vet to BOD & Audit Committee

March 24, 2022

Akili Adds Gaming Vet as Chief Product Officer

March 17, 2022

Gelesis: Record-Breaking Plenity Prescriptions

March 16, 2022

Akili Named to World's Most Innovative Companies

March 8, 2022

Akili Data: Enhanced Brain Activity in Kids w/ADHD

February 17, 2022

PRTC's Akili Files Registration Statement on S-4

February 15, 2022

PRTC's Gelesis Launches Plenity Media Campaign

January 31, 2022

PRTC's Akili to Become Public & $162M Funding

January 26, 2022

PRTC's Gelesis to Debut on NYSE Today Ticker GLS

January 14, 2022

PureTech to Present at JPM Healthcare Conference

January 7, 2022

LYT-100 Shows Improved AE Profile vs Pirfenidone

January 6, 2022

← Newer · Older →